SITC Cancer Immunotherapy CONNECT

 

Regular and Late-Breaking Abstract Titles for the 32nd Annual Meeting Now Available

Regular and late-breaking abstract titles of research to be unveiled at the SITC 2017 Annual Meeting are published! Browse abstract titles then register to join SITC in National Harbor this November.


Browse Abstract Titles

sitc-connect-ed-cmyk_FINAL.png

New to SITC connectED: Advances in Cancer Immunotherapy™ 2017 Video Series

Now in the SITC connectED Class Catalog, register for the Advances in Cancer Immunotherapy™ 2017 Video Series. This free online class will facilitate understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments, strategies for overcoming operational and reimbursement barriers and much more.

Register for the Class

Registration Fees Waived for December 2 ACI Program in Houston

Join SITC on Dec. 2 in Houston, Texas to learn clinical applications of immunotherapy for disease states with FDA-approved treatments. In support of those affected by Hurricane Harvey, all registration fees for this program are waived.

REGISTER Now

sitc17-mobile-app-5x5-v2.png

THERE'S AN APP FOR THAT

Download the SITC 2017 Meeting App and get the most our of your 32nd Annual Meeting & Pre-Conference Programs experience.

App_store_2.png google_play41b1436a274e994aa7.png

Learn more

Sparkathon_Logo_PNG.png

29 Young Investigators Leading 2017 SITC Sparkathon Cohort

The SITC Sparkathon, a long-awaited new program enlisting young investigators to identify and solve hurdles facing the field of cancer immunotherapy, has launched! Learn more about the program and the 29 early career scientists who comprise the 2017 Cohort of the SITC Sparkathon.

Meet the 2017 Cohort

SITC-blk.png

The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

sitc_log_white.png

Join the Community– Create a Free SITC Cancer Immunotherapy CONNECT Account

Learn and share information in the SITC Cancer Immunotherapy CONNECT Open Forum! Create a free SITC CONNECT account in a few minutes, upload a profile photo and then join the conversation.

CREATE A SITC CONNECT ACCOUNT

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Therapy-related myeloid neoplasms (WHO classification) with mutated TP53 or complex chromosome aberrations are not likely to be cured with targeted agents. These neoplasms comprise a group of clonal hematopoietic stem cell disorders related to prior ...

  • The Department of Immunology, Genetics and Pathology (IGP) at Uppsala University in Sweden is involved in an ongoing effort to collect cancer patient data in an initiative entitled U-CAN.  By June of this year, the biobank has grown to approximately ...

  • It is the recent modest single agent activity of programmed death-ligand 1 and programmed death receptor-1 antibodies for those with breast cancer that is generating hope for use of immunotherapy in breast cancer. To ponder in the meantime, in preparation ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More